Subscribe

Daniel Perlman, Milliman Inc

Articles by Daniel Perlman, Milliman Inc

Medical-Claims Database Analysis of Off-Label Prescribing

ByBy Jill Van Den Bos,Daniel Perlman, Milliman Inc

June 27th 2010

Examining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage

Latest Updated Articles

Medical-Claims Database Analysis of Off-Label Prescribing
June 27th 2010

Trending on Pharmaceutical Commerce

FAQ: The Medicare GLP-1 Bridge Program

How AI and CGTs Are Reshaping Pharma 3PL

TrumpRx Adds 160 More Drugs: Why the Latest Expansion Matters

FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?

Q&A: Why Pharma Supply Chains Are Turning to AI